-
EP4285920
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4285920
| EP4285920 - COMPOSITION FOR USE AS AN ANTIVIRAL IN THE FORM OF NASAL DROPS AND IN NEBULISERS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.11.2023 Database last updated on 18.11.2024 | |
| Former | The international publication has been made Status updated on 05.08.2022 | Most recent event Tooltip | 24.09.2024 | Supplementary search report | published on 23.10.2024 [2024/43] | Applicant(s) | For all designated states Dermopartners, S.L. c/ Massamagrell nº 3 46138 Rafelbunyol - Valencia / ES | [2023/49] | Inventor(s) | 01 /
SERRANO SANMIGUEL, Gabriel 46138 Rafelbunyol - Valencia / ES | [2023/49] | Representative(s) | Urizar Anasagasti, Jesus Maria, et al IPAMARK, S.L. C/ Segre 27- 1° 28002 Madrid / ES | [2023/49] | Application number, filing date | 21922702.2 | 01.02.2021 | [2023/49] | WO2021ES70076 | Filing language | ES | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022162254 | Date: | 04.08.2022 | Language: | ES | [2022/31] | Type: | A1 Application with search report | No.: | EP4285920 | Date: | 06.12.2023 | Language: | EN | [2023/49] | Search report(s) | International search report - published on: | ES | 04.08.2022 | (Supplementary) European search report - dispatched on: | EP | 23.09.2024 | Classification | IPC: | A61K9/72, A61K9/127, A61K38/40, A61K31/79, A61K38/44, A61P31/14 | [2024/43] | CPC: |
A61K33/18 (EP);
A61K9/127 (EP,US);
A61K38/40 (EP,US);
A61K38/44 (US);
A61K38/443 (EP);
A61K47/32 (EP);
| C-Set: |
A61K33/18, A61K2300/00 (EP);
A61K38/40, A61K2300/00 (EP);
A61K38/443, A61K2300/00 (EP)
|
| Former IPC [2023/49] | A61K38/40, A61K31/79, A61K38/44, A61K9/72, A61P31/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/49] | Title | German: | ZUSAMMENSETZUNG ZUR VERWENDUNG ALS ANTIVIRALES MITTEL IN FORM NASALER TROPFEN UND IN VERNEBLERN | [2023/49] | English: | COMPOSITION FOR USE AS AN ANTIVIRAL IN THE FORM OF NASAL DROPS AND IN NEBULISERS | [2023/49] | French: | COMPOSITION DESTINÉE À ÊTRE UTILISÉE SOUS FORME DE GOUTTES NASALES ET NÉBULISATEURS À ACTION ANTIVIRALE | [2023/49] | Entry into regional phase | 21.07.2023 | Translation filed | 28.08.2023 | National basic fee paid | 28.08.2023 | Search fee paid | 28.08.2023 | Designation fee(s) paid | 28.08.2023 | Examination fee paid | Examination procedure | 28.08.2023 | Examination requested [2023/49] | Fees paid | Renewal fee | 28.08.2023 | Renewal fee patent year 03 | 12.02.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO0172262 (SCHOTT GLAS [DE], et al); | [A]US2009246146 (BANFI BOTOND [US], et al); | [A]WO2020232515 (FIREBRICK PHARMA PTY LTD [AU]); | [A]WO2020250209 (SOFAR SPA [IT]); | by applicant | WO2020ES70245 |